context of specific organ systems, rather than expecting to uncover universal cellular markers which presage Baylor College of Medicine Houston, Texas 77030 aging in every organ system. From a medical and therapeutic perspective, it will ultimately become important to relate the pathways that regulate longevity in general to the onset of aging-related diseases in specific cell Human aging is characterized by debilitating diseases, lineages. including heart failure, cardiac pacemaker defects, Recent studies are now pointing to both similarities muscle wasting, and osteoporosis, in heart, skeletal and important differences between the core genetic muscle, and bone. Recent studies are identifying program that governs organismal longevity in general pathways for these aging-related diseases by examinand those that regulate key phenotypic features of ing how the process of aging influences tissue-speaging-related diseases in specific organ systems. This cific progenitors and differentiated cell lineages in brief review will highlight advances in three organ systhese organ systems. These advances form a foundatems, heart, skeletal muscle, and bone, which are betion for new therapeutic strategies to delay the onset ginning to form a molecular framework for the integof aging-related disorders.
During the earliest stages of in vivo cardiogenesis, islet-1, a LIM homeodomain transcription factor, marks the secondary heart field and identifies a group of cardiac progenitors that ultimately form the right side of the heart and the outflow tract. Cre recombinase-mediated lineage tracing in the mouse documents that these progenitors can ultimately give rise to both ventricular (MLC2-V+) and atrial cell lineages (sarcolipin+) (Cai et al., 2003) . A rare subset of these islet-1 progenitors persists in the right side of the postnatalhearts of mouse, rat, and humans (Laugwitz et al., 2005) . In the mouse, the islet-1 progenitor pool can be expanded on cardiac mesenchymal cell feeder layers that release a progenitor renewal factor (Laugwitz et al., 2005) . The purified progenitors can spontaneously downregulate islet-1 expression and subsequently enter a fully differentiated ventricular cardiomyocyte phenotype. In addition, a subset of the progenitor-derived cardiomyocytes display spontaneous pacemaking activity, suggesting the possibility of their entry into a conduction system-like lineage (Laugwitz et al., 
2005). This latter point remains to be formally proven by in vivo lineage tracing and direct measurement of pacemaker channel function (HCN+). Figure adapted from Laugwitz et al. (2005).
heart disease and are also likely to play a role in aginggrowing body of evidence now supports a pivotal role for the loss of viable myocytes during continued biorelated diseases as well.
In this regard, disorders in cardiac contractility, relaxmechanical stress as a major trigger for many of these age-related cardiac diseases, such as heart failure (for ation, conduction, and pacemaker function are some of the most prevalent features of human aging (Schwartz review, see Crow et al., 2004) . Since each of these cardiac phenotypes is based on defects in specific and Zipes, 2005). Recent advances are beginning to uncover pathways in specific cardiac lineages, i.e., atcardiac lineages (pacemaker cell lineages, conduction cell lineages, atrial myocytes, ventricular muscle cells), rial, ventricular, and conduction system, that lead to these disease phenotypes (Figure 2) (for review see there is a possibility of utilizing a well-characterized battery of cardiovascular cell type-restricted cre mice Chien and Olson, 2002 and references therein). One of the most common defects in the aging heart lies within (for review, see Ruiz-Lozano and Chien, 2003) to dissect how specific molecular pathways that govern the the cardiac conduction system, where there can be specific dysfunction of cardiac pacemaker cells in the general program of longevity in the whole organism intersect with cardiac cell-specific programs that regusinoatrial node leading to the onset of marked slowing of the basal heart rate that often necessitates pacelate and/or maintain normal physiological function within these cell types. As noted below, recent studies maker implantation. In atrial lineages, the defects in conduction can lead to the complete loss of organized have begun to use the heart as a system to study the biological pathways that govern aging in general. atrial contraction and the onset of atrial fibrillation, a common disorder in the aging human heart that often leads to an increased risk for the formation of atrial mtDNA Mutations Directly Lead to the Onset of an Aging Heart Phenotype and Generalized blood clots and subsequent embolic stroke. In the ventricular chamber, before the development of overt heart Features of Human Aging During the normal course of human aging, there is a failure, a selective impairment in cardiac relaxation can appear that is associated with defects in calcium cyprogressive accumulation of mutations in mitochondrial DNA in multiple differentiated cell types, including both cling (Schmidt et al., 2000) . Decreases in the activity of the cardiac muscle calcium pump have been shown to heart and skeletal muscle. Pioneering studies by Wallace and others have noted that this increasing burden be pivotal for heart failure progression in experimental animal models and in rare monogenic forms of human of mitochondrial mutations correlates with the onset of defects in oxidative phosphorylation in mitochondria dilated cardiomyopathy (Minamisawa et During the course of human aging, cardiac defects arise that reflect the influence of the aging process on distinct cell lineages. In the aging atrium, there is a marked increase in the onset of atrial fibrillation, an arrhythmia that is associated with the complete loss of organized atrial contraction. This loss of atrial contraction leads to pooling of blood in the atrium and the formation of blood clots that can give rise to embolic stroke, which is a major cause of cardiac morbidity in the elderly. In the ventricular chamber, there is an increased stiffness and tension, largely due to impairment of the activity of the cardiac calcium pump that triggers cardiac relaxation. This decrease in relaxation can promote the onset of heart failure, which is triggered by defects in calcium cycling (see text for details and references). In the cardiac conduction system, there can be a loss of regular pacemaker firing in the sinoatrial node that normally sets the heart beat, which can ultimately lead to a life-threatening slow heart rate (sick sinus syndrome) requiring electrical pacemaker implantation. In the aging atrioventricular node, there can be the onset of conduction system myocyte dropout and fibrosis that can lead to complete heart block, which also requires artificial pacemaker therapy. onset of mitochondrial dysfunction and the generation erated which harbors a selective mutation in the catalytic subunit of mitochondrial DNA polymerase PolgA of reactive oxygen species that, in turn, creates further mitochondrial DNA mutations. In this manner, a poten-(see Figure 3) . The mutation was designed to create defects in the proofreading function of the polymerase, tial vicious cycle is established that has been postulated to lead to the progressive onset of age-related leading to the progressive, random accumulation of mtDNA mutations during the course of mitochondrial phenotypes in heart muscle, including apoptosis and dysfunction in multiple cardiac lineages. However, it biogenesis. These mice display a completely normal phenotype at birth and in early adolescence but subsehas been widely appreciated that the level of mitochondrial mutations in the intact heart is relatively low, quently acquire many features of premature aging in the heart and multiple organ systems. As early as 40 affecting only a small proportion of muscle cells, resulting in considerable mosaicism. These results have sugweeks of age, the mitochondrial mutator mice display the onset of cardiomyopathy, as well as many other gested that the onset of mitochondrial mutations may not be driving the aging process in cardiac muscle. phenotypic features of human aging, including alopecia, graying of hair color, and osteoporosis (Figure 3 ). Given the technical difficulty of manipulating the mitochondrial genome, it has been difficult to directly test These aging-related phenotypes were found at a time when there was only a 3-to 5-fold increase in the whether mitochondrial mutations are causal to the onset of the aging heart phenotype or rather are simply mtDNA mutation load versus wild-type control levels in diverse tissues. Studies of isolated mitochondria from markers of the aging process.
A landmark study by Larsson and colleagues has the mutant heart document a significant, progressive defect in respiratory function despite a relatively low now provided evidence in direct support of the mtDNA mutation theory for aging in heart muscle and other difand mosaic mtDNA mutation load. Taken together, these studies represent the most compelling support ferentiated cell lineages (Trifunovic et al., 2004) . In these studies, a mitochondrial mutator mouse was genfor the mitochondrial theory of aging in heart and other In vertebrates, bone remodeling functions to maintain a constant bone mass, a process that is dysregua compelling case can now be made for the potential therapeutic role of myostatin in aging-related skeletal lated in osteoporosis. During bone remodeling, there is first a destruction of preexisting bone by a multinuclemuscle-wasting diseases. Further molecular insight into how myostatin exerts this effect on skeletal muscle ated cell type of hematopoietic origin, the osteoclast. This resorption phase of bone remodeling occurs mass, and its potential intersection with IGF-1 pathways, may uncover new therapeutic targets in the comsimultaneously at numerous sites in the skeleton and occurs relatively quickly, i.e., 3 weeks per site. This is ing years.
followed by the rebuilding of bones by the osteoblast, a cell type of mesenchymal origin, which lasts over 3 Aging and the Skeleton: Osteoclasts, Osteoblasts, months per site. In young adults, and typically between and Bone Remodeling the end of puberty and menopause in women, bone Human aging is also often associated with major deresorption and formation occur at the same rate so that fects on the skeleton itself. Aging-related bone disbone mass is constant. This equilibrium is altered by eases are comprised of three major classes: the erosion gonadal failure and aging in general, leading to a relaof the joints or osteoarthritis; an increase in bone retive increase in bone resorption, bone loss, and osteosorption leading to osteoporosis, a low bone mass disporosis (Riggs et al., 1998). Each arm of bone remodelease with high risk of fracture; and metastatic bone dising is subjected to two types of regulatory pathways: ease that relates to breast cancer in women or prostate local regulation which is exerted by factors secreted by cancer in men. Osteoarthritis and osteoporosis are not bone cells themselves; and systemic regulation exerted only the most frequent degenerative diseases of the by hormones that often impinge upon the expression skeleton, they are also the most frequent degenerative of local factors. diseases in developed countries (Cooper and Melton, 1996) . Their incidence, and the public health burden they represent, justify the considerable effort made by Local Regulation of Bone Remodeling in Specific Cell Lineages physiologists, molecular biologists, and geneticists to decipher how the integrity of joints is conserved, as Our most advanced molecular understanding of bone remodeling came initially from a series of elegant well as how bone mass is regulated. To date, much prog- The next frontier in aging-related bone diseases lies in the unraveling of the pathophysiology of cancer megists interested in the consequences of aging in the skeleton. The success of the field in tackling these two tastases to bone. Although several malignancies can metastisize to bone, two types of human cancer have challenges will depend on our ability to develop novel therapies for osteoporosis. dominated this area of research: breast cancer, which causes bone destruction, and prostate cancer, which The first, longstanding challenge is to elucidate how gonadal failure in either sex leads to an increase in causes bone formation. Pioneering work has implicated TGFβ as the main factor promoting breast cancer bone bone resorption. Given the importance of this question clinically, it is in fact astounding to realize how little we metastases via the expression of PTH-related peptide (PTHrP), a secreted growth factor (for review, see Guise know about the mechanisms leading to low bone mass after menopause. Is this an effect of sex steroid depleand Mundy, 1998). How PTHrP enhances bone resorption is not fully understood, and the molecular pathtion or of the depletion of other molecules as discussed above? If it is a direct effect of the sex steroids, is it ways remain unclear. As for prostate cancer, the molecular pathways leading to the formation of prostatic a transcriptional and/or nontranscriptional effect? The newer challenge, possibly linked to the previous one, is bone metastases are also unknown. With the progressive aging of the population in developed counto define how the central control of bone mass is affected during aging and/or at the time of gonadal failure tries, a marked increase in the incidence of prostate cancer could be expected, and this area will likely beand how it therefore contributes to the pathophysiology of osteoporosis. Based on the identification of regulacome a major focus of research on aging-related bone diseases in the future. Progress in this field will untors of bone resorption such as RANKL or OPG, novel drugs are already being tested that would slow down doubtedly be greatly helped by the recent elucidation of the pathways which guide the differentiation and bone resorption. The consensus in the field, however, is that given the efficacy of currently available antirefunction of osteoclast and osteoblast lineages. sorption drugs, therapeutic approaches which promote bone formation, i.e., anabolic agents, are the ones most Toward the In Vivo Integrative Biology of Human Aging needed. Thus, by solving the enigma of how gonadal failure leads to low bone mass and determining the imThe dramatic growth in our understanding of the genetic program that governs organismal life span has portance of the central control of bone mass in the context of aging, we will be in a position to further now provided a framework for understanding how these pathways influence the onset of age-related disbroaden our therapeutic arsenal. eases in multiple organ systems. These organ systems represent a tractable system to test insights estabNew Frontiers in Aging and Skeletal Biology:
lished in model organisms in the more complex setting Osteoarthritis and Metastatic Bone Disease of human biology and disease. To unlock the potential Aging-related bone phenotypes also include other of dissecting cell type-specific aging pathways in these degenerative processes, such as osteoarthritis and complex organ systems, it will be crucial to develop a metastatic bone diseases. Currently, our knowledge rephysiological and molecular map of changes in specific garding the pathophysiology of both of these bone discell lineages in heart (pacemaker, conduction system orders is still very limited. myocyte, atrial, ventricular), skeletal muscle, and bone One of the major reasons for our limited understand-(osteoclast, osteoblast). Optimally, these databases ing of the pathophysiology of osteoarthritis is the lack would be generated as a function of aging in specific of specific molecular markers of articular chondrocell lineages in the absence of other overt diseases in cytes. Recently, two molecules were shown to be rethese organ systems. At a cellular level, it will be of quired to form joint cavities, 
